RSV Vaccine
Participation Criteria:
- Currently enrolling participants age 60 and up
*other criteria to be assessed
About This Study:
- Older adults are at an increased risk for a severe RSV infection which can lead to hospitalization and death especially at risk groups include: > 65 years old, chronic heart/lung disease, and/or weakened immune system.
- RSV is also very dangerous in infants – Especially at risk groups are premature infants, <6 months of age and/or children with chronic heart/lung disease or weakened immune systems.
- Symptoms in otherwise healthy adults are generally very mild so they can unknowingly pass RSV to children (which is why vaccinations are so important!)
- 1-2 children out of every 100 less than 6 months of age will need to be hospitalized due to RSV.
- RSV is the #1 cause of serious respiratory tract disease in infancy and early childhood worldwide.
- Among the elderly, RSV-associated disease rates are similar to that of the flu.
- In elderly adults, RSV is one of the leading causes of pneumonia.
Investigators:
